Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
12 May 2021 | Story Ilze Bakkes
The COVID-19 outbreak in South Africa and the subsequent national lockdown severely impacted the usual physical open day mass-marketing tactic. At the same time, it provided an opportunity for the Department of Student Recruitment Services (SRS) to be super creative and agile in promoting the UFS offerings to the target audiences. 

Once a year, the UFS invites prospective learners and parents to visit our campuses for a taste of campus life. But for many interested students, especially those living remotely or abroad, a site visit is not always practical. Furthermore, the 2021 open days on the Bloemfontein and Qwaqwa Campuses were again cancelled due to the COVID-19 pandemic. The 2020 Virtual Open Day proved that breaking from the traditional recruitment tactics and moving into the virtual domain was not only bold and innovative, but also offered more engagement and communication opportunities with prospective students. Building on the insights and success of COVID-19 response engagements, the Department of Student Recruitment Services has once again developed an immersive virtual experience for prospective students. 

Ilze Bakkes, Chief Officer: Integrated Marketing and Innovation from the Department of Student Recruitment Services, says: “We listened to the needs and wants of our prospective students and staff. Therefore, the 2021 Virtual Expo will have undergraduate, postgraduate, and international student recruitment foci, offering more and relevant information in a visual, multi-layered, and digital way.” Information is presented through videos, photos, downloadable PDF brochures, and links to marketing material and the online application platform. 

A challenge during the physical open day is the lack of time to engage with faculties or that not all the information could be obtained. The Virtual Expo is live now click here and can be visited until 30 September 2021, when applications to study undergraduate and postgraduate programmes in 2022 close. The Virtual Expo offers a professional, easy-to-navigate and hassle-free digital experience of the academic, social, and cultural life at the UFS on all three campuses – in the convenience of the visitor’s own space and time. Subtexts for videos enable differently abled visitors to enjoy the content, and data-sensitive visitors can download the PDF versions of videos. 

Applications to study in 2022 are already open. To apply, click here (link to online application). For important closing dates, download the UFS Undergraduate Prospectus

For information on the Virtual Expo, contact Ilze Bakkes at +27 51 401 9028 or bakkese@ufs.ac.za.

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept